🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06796933
Starting soon Not applicable

Effect of Bioptron on Scar Formation After Cesarean Section

NCT06796933 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-01-27
Last updated
2025-01-28

Condition(s) studied

Cesarean Section

Investigational drug(s) / intervention(s)

Silicon based products (silicon gel)Bioptron (polarized light therapy)

Silicon based products (silicon gel): The participants will be treated with cosmetic creams such as Silicone-based products (silicone gels twice a day) for one month.

Bioptron (polarized light therapy): The participants will be treated by polarized light therapy (Bioptron) for 15 minutes, 3 sessions per week, for one month.

Study summary

The purpose of the study will be to determine the effect of polarized light therapy (Bioptron) on scar formation after a cesarean section.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: * The participants' ages will be ranged from 20-30 years old. * Their body mass index (BMI) will not exceed 30 kg/m2. * They will be primipara and having abdominal scar after CS. * The scar age will be extended from 6 weeks to 6 months. * All women will be medically stable when attending the study. Exclusion Criteria: * Pregnant women or women planning to become pregnant during the study period. * Women having diabetes mellitus. * Women taking immunosuppressant drugs.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ghadeer Abdelazim Mostafa Banhā Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06796933 on ClinicalTrials.gov ↗ ← All trials in Egypt